Gordon Mills Selected Research

Gordon Mills Research Topics

Disease

17	Neoplasms (Cancer) 11/2021 - 01/2005
5	Melanoma (Melanoma, Malignant) 11/2021 - 01/2013
4	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2006
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2014
2	Glioma (Gliomas) 12/2021 - 06/2015
2	Hypoxia (Hypoxemia) 01/2012 - 12/2008
2	Lung Neoplasms (Lung Cancer) 08/2010 - 05/2008
1	COVID-19 12/2021
1	ST Elevation Myocardial Infarction 12/2021
1	Myocardial Infarction 12/2021
1	Nevus (Nevi) 12/2018
1	Carcinoma (Carcinomatosis) 05/2009
1	Squamous Cell Carcinoma of Head and Neck 03/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2009
1	Parkinson Disease (Parkinson's Disease) 12/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2008
1	Glioblastoma (Glioblastoma Multiforme) 05/2008
1	Ovarian Epithelial Carcinoma 03/2008
1	Ascites 01/2007
1	Carcinogenesis 11/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
2	Biological ProductsIBA 01/2022 - 01/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 10/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2015 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2015
2	lysophosphatidic acidIBA 01/2012 - 01/2007
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 03/2009
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Ribose (D-Ribose)IBA 01/2022
1	PlatinumIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 12/2021
1	NucleosidesIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 12/2021
1	alpha-2'-deoxythioguanosineIBA 12/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	IronIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 06/2015
1	RNA (Ribonucleic Acid)IBA 06/2015
1	Messenger RNA (mRNA)IBA 06/2015
1	ChromatinIBA 01/2014
1	raf KinasesIBA 01/2013
1	Lysophosphatidic Acid ReceptorsIBA 01/2012
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2012
1	Steroid Receptors (Steroid Receptor)IBA 08/2010
1	Gefitinib (Iressa)FDA Link 08/2010
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 08/2010
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2010
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	TensinsIBA 05/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2009
1	Antisense DNAIBA 03/2009
1	deguelinIBA 12/2008
1	Protein Isoforms (Isoforms)IBA 05/2008
1	Complementary DNA (cDNA)IBA 05/2008
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2008
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2008
1	Oral ContraceptivesIBA 03/2008
1	Conditioned Culture MediaIBA 01/2007
1	lysophosphatidylinositolIBA 01/2007
1	LysophospholipidsIBA 01/2007
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2007
1	lysophosphatidylserineIBA 01/2007
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2007
1	EnzymesIBA 01/2007
1	sphingosine phosphorylcholineIBA 01/2007
1	Estrogen Receptor alphaIBA 11/2006
1	I-kappa B KinaseIBA 11/2006

Therapy/Procedure

8	Therapeutics 11/2021 - 01/2007
2	Chemoprevention 12/2008 - 01/2005
1	Percutaneous Coronary Intervention 12/2021
1	Drug Therapy (Chemotherapy) 03/2008